SHIRPA primary screen were successfully applied to CD36−/− mice and C57BL/6J mice.
CD36−/− mice displayed increased aggression and locomotor activity in SHIRPA primary screen.
Multiple neuropsychiatric diseases (mainly depression and anxiety) related behavioral tests were conducted in CD36−/− mice and C57BL/6J mice.
CD36−/− mice showed increased anxiety-like behavior.